 | • レポートコード：GIR-2104Z00722 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、αサラセミアのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。αサラセミアの種類別市場規模（鉄キレート薬、遺伝子治療）、用途別市場規模（病院、私立診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・αサラセミアの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bluebird Bio、Novartis、Kiadis Pharma、Acceleron Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：鉄キレート薬、遺伝子治療 ・用途別分析2016年-2026年：病院、私立診療所、その他 ・αサラセミアの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・αサラセミアのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・αサラセミアのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・αサラセミアの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・αサラセミアの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Alpha Thalassemia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Alpha Thalassemia size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Alpha Thalassemia market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Alpha Thalassemia market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Iron Chelating Drugs
Gene Therapy
Market segment by Application, can be divided into
Hospitals
Private clinics
Other
Market segment by players, this report covers
Bluebird Bio
Novartis
Kiadis Pharma
Acceleron Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Alpha Thalassemia
1.2 Classification of Alpha Thalassemia by Type
1.2.1 Overview: Global Alpha Thalassemia Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Alpha Thalassemia Revenue Market Share by Type in 2020
1.2.3 Iron Chelating Drugs
1.2.4 Gene Therapy
1.3 Global Alpha Thalassemia Market by Application
1.3.1 Overview: Global Alpha Thalassemia Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Private clinics
1.3.4 Other
1.4 Global Alpha Thalassemia Market Size & Forecast
1.5 Global Alpha Thalassemia Market Size and Forecast by Region
1.5.1 Global Alpha Thalassemia Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Alpha Thalassemia Market Size by Region, (2016-2021)
1.5.3 North America Alpha Thalassemia Market Size and Prospect (2016-2026)
1.5.4 Europe Alpha Thalassemia Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Alpha Thalassemia Market Size and Prospect (2016-2026)
1.5.6 South America Alpha Thalassemia Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Alpha Thalassemia Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Alpha Thalassemia Market Drivers
1.6.2 Alpha Thalassemia Market Restraints
1.6.3 Alpha Thalassemia Trends Analysis
2 Company Profiles
2.1 Bluebird Bio
2.1.1 Bluebird Bio Details
2.1.2 Bluebird Bio Major Business
2.1.3 Bluebird Bio Alpha Thalassemia Product and Solutions
2.1.4 Bluebird Bio Alpha Thalassemia Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bluebird Bio Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Alpha Thalassemia Product and Solutions
2.2.4 Novartis Alpha Thalassemia Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Kiadis Pharma
2.3.1 Kiadis Pharma Details
2.3.2 Kiadis Pharma Major Business
2.3.3 Kiadis Pharma Alpha Thalassemia Product and Solutions
2.3.4 Kiadis Pharma Alpha Thalassemia Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Kiadis Pharma Recent Developments and Future Plans
2.4 Acceleron Pharma
2.4.1 Acceleron Pharma Details
2.4.2 Acceleron Pharma Major Business
2.4.3 Acceleron Pharma Alpha Thalassemia Product and Solutions
2.4.4 Acceleron Pharma Alpha Thalassemia Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Acceleron Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Alpha Thalassemia Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Alpha Thalassemia Players Market Share
3.2.2 Top 10 Alpha Thalassemia Players Market Share
3.2.3 Market Competition Trend
3.3 Alpha Thalassemia Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Alpha Thalassemia Revenue and Market Share by Type (2016-2021)
4.2 Global Alpha Thalassemia Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Alpha Thalassemia Revenue Market Share by Application (2016-2021)
5.2 Alpha Thalassemia Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Alpha Thalassemia Revenue by Type (2016-2026)
6.2 North America Alpha Thalassemia Revenue by Application (2016-2026)
6.3 North America Alpha Thalassemia Market Size by Country
6.3.1 North America Alpha Thalassemia Revenue by Country (2016-2026)
6.3.2 United States Alpha Thalassemia Market Size and Forecast (2016-2026)
6.3.3 Canada Alpha Thalassemia Market Size and Forecast (2016-2026)
6.3.4 Mexico Alpha Thalassemia Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Alpha Thalassemia Revenue by Type (2016-2026)
7.2 Europe Alpha Thalassemia Revenue by Application (2016-2026)
7.3 Europe Alpha Thalassemia Market Size by Country
7.3.1 Europe Alpha Thalassemia Revenue by Country (2016-2026)
7.3.2 Germany Alpha Thalassemia Market Size and Forecast (2016-2026)
7.3.3 France Alpha Thalassemia Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Alpha Thalassemia Market Size and Forecast (2016-2026)
7.3.5 Russia Alpha Thalassemia Market Size and Forecast (2016-2026)
7.3.6 Italy Alpha Thalassemia Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Alpha Thalassemia Revenue by Type (2016-2026)
8.2 Asia-Pacific Alpha Thalassemia Revenue by Application (2016-2026)
8.3 Asia-Pacific Alpha Thalassemia Market Size by Region
8.3.1 Asia-Pacific Alpha Thalassemia Revenue by Region (2016-2026)
8.3.2 China Alpha Thalassemia Market Size and Forecast (2016-2026)
8.3.3 Japan Alpha Thalassemia Market Size and Forecast (2016-2026)
8.3.4 South Korea Alpha Thalassemia Market Size and Forecast (2016-2026)
8.3.5 India Alpha Thalassemia Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Alpha Thalassemia Market Size and Forecast (2016-2026)
8.3.7 Australia Alpha Thalassemia Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Alpha Thalassemia Revenue by Type (2016-2026)
9.2 South America Alpha Thalassemia Revenue by Application (2016-2026)
9.3 South America Alpha Thalassemia Market Size by Country
9.3.1 South America Alpha Thalassemia Revenue by Country (2016-2026)
9.3.2 Brazil Alpha Thalassemia Market Size and Forecast (2016-2026)
9.3.3 Argentina Alpha Thalassemia Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Alpha Thalassemia Revenue by Type (2016-2026)
10.2 Middle East & Africa Alpha Thalassemia Revenue by Application (2016-2026)
10.3 Middle East & Africa Alpha Thalassemia Market Size by Country
10.3.1 Middle East & Africa Alpha Thalassemia Revenue by Country (2016-2026)
10.3.2 Turkey Alpha Thalassemia Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Alpha Thalassemia Market Size and Forecast (2016-2026)
10.3.4 UAE Alpha Thalassemia Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Alpha Thalassemia Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Alpha Thalassemia Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Alpha Thalassemia Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Alpha Thalassemia Revenue (USD Million) by Region (2016-2021)
Table 5. Global Alpha Thalassemia Revenue Market Share by Region (2021-2026)
Table 6. Bluebird Bio Corporate Information, Head Office, and Major Competitors
Table 7. Bluebird Bio Major Business
Table 8. Bluebird Bio Alpha Thalassemia Product and Solutions
Table 9. Bluebird Bio Alpha Thalassemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Alpha Thalassemia Product and Solutions
Table 13. Novartis Alpha Thalassemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Kiadis Pharma Corporate Information, Head Office, and Major Competitors
Table 15. Kiadis Pharma Major Business
Table 16. Kiadis Pharma Alpha Thalassemia Product and Solutions
Table 17. Kiadis Pharma Alpha Thalassemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Acceleron Pharma Corporate Information, Head Office, and Major Competitors
Table 19. Acceleron Pharma Major Business
Table 20. Acceleron Pharma Alpha Thalassemia Product and Solutions
Table 21. Acceleron Pharma Alpha Thalassemia Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Global Alpha Thalassemia Revenue (USD Million) by Players (2019-2021)
Table 23. Global Alpha Thalassemia Revenue Share by Players (2019-2021)
Table 24. Breakdown of Alpha Thalassemia by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. Alpha Thalassemia Players Head Office, Products and Services Provided
Table 26. Alpha Thalassemia Mergers & Acquisitions in the Past Five Years
Table 27. Alpha Thalassemia New Entrants and Expansion Plans
Table 28. Global Alpha Thalassemia Revenue (USD Million) by Type (2016-2021)
Table 29. Global Alpha Thalassemia Revenue Share by Type (2016-2021)
Table 30. Global Alpha Thalassemia Revenue Forecast by Type (2021-2026)
Table 31. Global Alpha Thalassemia Revenue by Application (2016-2021)
Table 32. Global Alpha Thalassemia Revenue Forecast by Application (2021-2026)
Table 33. North America Alpha Thalassemia Revenue by Type (2016-2021) & (USD Million)
Table 34. North America Alpha Thalassemia Revenue by Type (2021-2026) & (USD Million)
Table 35. North America Alpha Thalassemia Revenue by Application (2016-2021) & (USD Million)
Table 36. North America Alpha Thalassemia Revenue by Application (2021-2026) & (USD Million)
Table 37. North America Alpha Thalassemia Revenue by Country (2016-2021) & (USD Million)
Table 38. North America Alpha Thalassemia Revenue by Country (2021-2026) & (USD Million)
Table 39. Europe Alpha Thalassemia Revenue by Type (2016-2021) & (USD Million)
Table 40. Europe Alpha Thalassemia Revenue by Type (2021-2026) & (USD Million)
Table 41. Europe Alpha Thalassemia Revenue by Application (2016-2021) & (USD Million)
Table 42. Europe Alpha Thalassemia Revenue by Application (2021-2026) & (USD Million)
Table 43. Europe Alpha Thalassemia Revenue by Country (2016-2021) & (USD Million)
Table 44. Europe Alpha Thalassemia Revenue by Country (2021-2026) & (USD Million)
Table 45. Asia-Pacific Alpha Thalassemia Revenue by Type (2016-2021) & (USD Million)
Table 46. Asia-Pacific Alpha Thalassemia Revenue by Type (2021-2026) & (USD Million)
Table 47. Asia-Pacific Alpha Thalassemia Revenue by Application (2016-2021) & (USD Million)
Table 48. Asia-Pacific Alpha Thalassemia Revenue by Application (2021-2026) & (USD Million)
Table 49. Asia-Pacific Alpha Thalassemia Revenue by Region (2016-2021) & (USD Million)
Table 50. Asia-Pacific Alpha Thalassemia Revenue by Region (2021-2026) & (USD Million)
Table 51. South America Alpha Thalassemia Revenue by Type (2016-2021) & (USD Million)
Table 52. South America Alpha Thalassemia Revenue by Type (2021-2026) & (USD Million)
Table 53. South America Alpha Thalassemia Revenue by Application (2016-2021) & (USD Million)
Table 54. South America Alpha Thalassemia Revenue by Application (2021-2026) & (USD Million)
Table 55. South America Alpha Thalassemia Revenue by Country (2016-2021) & (USD Million)
Table 56. South America Alpha Thalassemia Revenue by Country (2021-2026) & (USD Million)
Table 57. Middle East & Africa Alpha Thalassemia Revenue by Type (2016-2021) & (USD Million)
Table 58. Middle East & Africa Alpha Thalassemia Revenue by Type (2021-2026) & (USD Million)
Table 59. Middle East & Africa Alpha Thalassemia Revenue by Application (2016-2021) & (USD Million)
Table 60. Middle East & Africa Alpha Thalassemia Revenue by Application (2021-2026) & (USD Million)
Table 61. Middle East & Africa Alpha Thalassemia Revenue by Country (2016-2021) & (USD Million)
Table 62. Middle East & Africa Alpha Thalassemia Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Alpha Thalassemia Picture
Figure 2. Global Alpha Thalassemia Revenue Market Share by Type in 2020
Figure 3. Iron Chelating Drugs
Figure 4. Gene Therapy
Figure 5. Alpha Thalassemia Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Private clinics Picture
Figure 8. Other Picture
Figure 9. Global Alpha Thalassemia Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Alpha Thalassemia Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Alpha Thalassemia Revenue Market Share by Region (2016-2026)
Figure 12. Global Alpha Thalassemia Revenue Market Share by Region in 2020
Figure 13. North America Alpha Thalassemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Alpha Thalassemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Alpha Thalassemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Alpha Thalassemia Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Alpha Thalassemia Market Drivers
Figure 18. Alpha Thalassemia Market Restraints
Figure 19. Alpha Thalassemia Market Trends
Figure 20. Bluebird Bio Recent Developments and Future Plans
Figure 21. Novartis Recent Developments and Future Plans
Figure 22. Kiadis Pharma Recent Developments and Future Plans
Figure 23. Acceleron Pharma Recent Developments and Future Plans
Figure 25. Global Alpha Thalassemia Revenue Share by Players in 2020
Figure 26. Alpha Thalassemia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 27. Global Top 3 Players Alpha Thalassemia Revenue Market Share in 2020
Figure 28. Global Top 10 Players Alpha Thalassemia Revenue Market Share in 2020
Figure 29. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 30. Global Alpha Thalassemia Revenue Share by Type in 2020
Figure 31. Global Alpha Thalassemia Market Share Forecast by Type (2021-2026)
Figure 32. Global Alpha Thalassemia Revenue Share by Application in 2020
Figure 33. Global Alpha Thalassemia Market Share Forecast by Application (2021-2026)
Figure 34. North America Alpha Thalassemia Sales Market Share by Type (2016-2026)
Figure 35. North America Alpha Thalassemia Sales Market Share by Application (2016-2026)
Figure 36. North America Alpha Thalassemia Revenue Market Share by Country (2016-2026)
Figure 37. United States Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Canada Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Mexico Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Europe Alpha Thalassemia Sales Market Share by Type (2016-2026)
Figure 41. Europe Alpha Thalassemia Sales Market Share by Application (2016-2026)
Figure 42. Europe Alpha Thalassemia Revenue Market Share by Country (2016-2026)
Figure 43. Germany Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. France Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. United Kingdom Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Russia Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Italy Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Alpha Thalassemia Sales Market Share by Type (2016-2026)
Figure 49. Asia-Pacific Alpha Thalassemia Sales Market Share by Application (2016-2026)
Figure 50. Asia-Pacific Alpha Thalassemia Revenue Market Share by Region (2016-2026)
Figure 51. China Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Japan Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. South Korea Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. India Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Southeast Asia Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Australia Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South America Alpha Thalassemia Sales Market Share by Type (2016-2026)
Figure 58. South America Alpha Thalassemia Sales Market Share by Application (2016-2026)
Figure 59. South America Alpha Thalassemia Revenue Market Share by Country (2016-2026)
Figure 60. Brazil Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Argentina Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Middle East and Africa Alpha Thalassemia Sales Market Share by Type (2016-2026)
Figure 63. Middle East and Africa Alpha Thalassemia Sales Market Share by Application (2016-2026)
Figure 64. Middle East and Africa Alpha Thalassemia Revenue Market Share by Country (2016-2026)
Figure 65. Turkey Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Saudi Arabia Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. UAE Alpha Thalassemia Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Methodology
Figure 69. Research Process and Data Source
世界のアルファサラセミア市場規模・現状・予測（2021年-2027年） Thalassemia is a general term for a group of inheritable blood disorders, in which the body produces abnormal hemoglobin, resulting in destruction of red blood cells. This ultimately leads to anemia. There are two main types of thalassemia: alpha-thalassemia and beta-thalassemia, the latter being mo…- 世界のサラセミア市場 2021：企業別、地域別、種類・用途別 The Thalassemia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent…
- 世界のαマンノース症市場 2021：企業別、地域別、種類・用途別 The Alpha Mannosidosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界のアルファマンノシドーシス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Alpha Mannosidosis Treatments Market The global Alpha Mannosidosis Treatments market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界のアルファエミッター市場規模・現状・予測（2021年-2027年） Alpha emitters are the radioactive substances which decay after emitting the alpha particles. Alpha emitter radionuclide is considered to be a new approach to treat many cancer types. Alpha particles offers the definite tumor cell slaughter action causing the less damage to adjacent normal tissues t…